| Today's Top Articles | |
 | Spain's patent moves to boost drug R&D Thursday 3rd July 2008 Spain's pharmaceutical industry is committed to increasing R&D spending from 6.5% of turnover at present to about 10% over the next few years, the Marketletter's European... more >> |
| European study of cardiovascular care: prevention pays, standards vary Thursday 3rd July 2008 Three of the four countries in Europe that spend the most per capita on cardiovascular disease prevention and care have topped a new index comparing 29 nations' performance... more >> |
| Stock Commentary - Europe - week to June 30, 2008 Thursday 3rd July 2008 EUROPEAN: bourses had another miserable reporting week to June 30, with much the same worries - the economy, oil prices and corporate earnings outlooks - impacting investor... more >> |
| Stock Commentary - New York week to June 30, 2008 Thursday 3rd July 2008 NEW YORK: equities mostly moved lower through the reporting week to June 30, with the Dow Jones seeing a 3% fall on June 26, due to ongoing problems in the financial... more >> |
| BSAC publishes UK guidelines on HAP treatment Thursday 3rd July 2008 The British Society for Antimicrobial Chemotherapy has published the first evidence-based UK guidelines to address the management of hospital-acquired pneumonia, which is... more >> |
| AZ and GSK face Iraqi claims for UN oil-for-food program Thursday 3rd July 2008 Officials in the Iraqi capital of Baghdad have begun criminal proceedings against a number of foreign companies, including UK drug major GlaxoSmithKline and Anglo-Swedish... more >> |
| Challenge to Indian patent on Roche's Valcyte by local firms Thursday 3rd July 2008 Indian generic drugmakers Cipla, Matrix Laboratories and HIV/AIDS advocacy group Delhi Network of Positive People recently filed an objection to a decision made last year... more >> |
| "Evergreening" mischaracterizes innovation, says PhRMA senior VP Thursday 3rd July 2008 The Pharmaceutical Research and Manufacturers of America's (PhRMA) senior vice president, Ken Johnson, has hit out at accusations made by supporters of follow-on biologics... more >> |